首页> 外文OA文献 >Beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

【2h】

Beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

机译：Beta-CA特异性抑制剂二硫代氨基甲酸酯Fc14-584B：一种新型抗分枝杆菌药，具有治疗耐药结核病的潜力

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Aspatwar, Ashok; Hammaren, Milka; Koskinen, Sanni; Luukinen, Bruno; Barker, Harlan; Carta, Fabrizio; Supuran, Claudiu T; Parikka, Mataleena; Parkkila, Seppo;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis [J] . Ashok Aspatwar, Milka Hammarén, Sanni Koskinen, Journal of enzyme inhibition and medicinal chemistry. . 2017,第1期

机译：β-CA特异性抑制剂二硫代氨基甲酸酯Fc14–584B：一种新型抗分枝杆菌药，具有治疗耐药结核病的潜力
2. Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II [J] . Alistair K. Brown, Athina Papaemmanouil, Veemal Bhowruth, Microbiology . 2007,第10期

机译：类黄酮抑制剂作为靶向RV0636的新型抗细菌剂，一种涉及结核分枝杆菌脂肪酸合成酶II的推定脱水酶
3. An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis [J] . Mori Matteo, Sanunartino Jose Camilla, Costantino Luca, Current topics in medicinal chemistry . 2019,第9期

机译：靶向结核分枝杆菌靶向丝氨酸/苏氨酸蛋白激酶的潜在抗致剂药物的概述
4. PHOSPHOPROTEOMICS OF NON-SMALL-CELL LUNG CANCER CELLS TREATED WITH ERLOTINIB REVEALS DRUG-RESISTANT SIGNATURES AND POTENTIAL TARGETS [C] . Jun Adachi, Yuichi Abe, Maiko Nagano, International Mass Spectrometry Conference . 2018

机译：用厄洛替尼处理的非小细胞肺癌细胞的磷脂蛋白酶揭示了耐药象征和潜在目标
5. Part I. Development of new organic synthetic methods: Palladium and copper catalyzed carbon-carbon, carbon-sulfur, carbon-nitrogen, and carbon-oxygen bond formation as well as DABCO-mediated stereospecific synthesis of acrylate ethers and amines. Part II. Design, synthesis and SAR studies of new classes of agents to treat drug-resistant bacteria, anthrax and tuberculosis infections. [D] . Kabir, Mohd Shahjahan. 2011

机译：第一部分：新的有机合成方法的开发：钯和铜催化的碳-碳，碳-硫，碳-氮和碳-氧键的形成，以及DABCO介导的丙烯酸酯醚和胺的立体有择合成。第二部分新型药物的设计，合成和SAR研究，用于治疗抗药性细菌，炭疽和肺结核感染。
6. β-CA-specific inhibitor dithiocarbamate Fc14–584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis [O] . Ashok Aspatwar, Milka Hammarén, Sanni Koskinen, 2017

机译：β-CA特异性抑制剂二硫代氨基甲酸酯Fc14–584B：一种新型抗分枝杆菌药具有治疗耐药结核病的潜力
7. 6-Alkyl-, 6-aryl- or 6-hetaryl-7-deazapurine ribonucleosides as inhibitors of human or MTB adenosine kinase and potential antimycobacterial agents [O] . Pavla Perlíková, Petr Konečný, Petr Nauš, 2013

机译：6-烷基 - ，6-芳基或6-丙芳基-7-二氮杂核糖核苷，作为人或MTB腺苷激酶和潜在抗致抗菌剂的抑制剂

Beta-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis

著录项

引文网络

相似文献

相关主题

期刊订阅